ATLANTA — Is opening the door for direct-to-consumer (DTC) genomic testing actually opening pandora's box? A small panel took on that question Tuesday during the American Association for Clincal Chemistry (AACC; Washington) meeting held here at the Georgia World Congress Center. (Medical Device Daily) Read More
